Ali Z Fadhel
Examiner (ID: 9147, Phone: (571)270-0267 , Office: P/1772 )
Most Active Art Unit | 1772 |
Art Unit(s) | 1772 |
Total Applications | 589 |
Issued Applications | 422 |
Pending Applications | 57 |
Abandoned Applications | 110 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17312699
[patent_doc_number] => 20210401747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => NANOPARTICLES CARRYING ANTIBIOTICS
[patent_app_type] => utility
[patent_app_number] => 17/472819
[patent_app_country] => US
[patent_app_date] => 2021-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472819
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472819 | Nanoparticles carrying antibiotics | Sep 12, 2021 | Issued |
Array
(
[id] => 18256887
[patent_doc_number] => 20230083927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => ELECTRONIC VAPOR LIQUID COMPOSITION AND METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 17/471475
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471475
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/471475 | ELECTRONIC VAPOR LIQUID COMPOSITION AND METHOD OF USE | Sep 9, 2021 | Abandoned |
Array
(
[id] => 17426710
[patent_doc_number] => 20220054418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => Methods for the preparation of biologically active compounds in nanoparticulate form
[patent_app_type] => utility
[patent_app_number] => 17/461713
[patent_app_country] => US
[patent_app_date] => 2021-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17461713
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/461713 | Methods for the preparation of biologically active compounds in nanoparticulate form | Aug 29, 2021 | Abandoned |
Array
(
[id] => 17256656
[patent_doc_number] => 20210369641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => SYSTEMS AND METHODS FOR FEEDING SUGAR ALCOHOL TO RUMINANTS DURING PERIODS OF HEAT STRESS
[patent_app_type] => utility
[patent_app_number] => 17/401178
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401178
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/401178 | Systems and methods for feeding sugar alcohol to ruminants during periods of heat stress | Aug 11, 2021 | Issued |
Array
(
[id] => 17368163
[patent_doc_number] => 20220023215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Lapatinib particles and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/381786
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17381786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/381786 | Lapatinib particles and uses thereof | Jul 20, 2021 | Abandoned |
Array
(
[id] => 17655476
[patent_doc_number] => 20220175941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS
[patent_app_type] => utility
[patent_app_number] => 17/373496
[patent_app_country] => US
[patent_app_date] => 2021-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373496
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/373496 | METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS | Jul 11, 2021 | Pending |
Array
(
[id] => 18125631
[patent_doc_number] => 20230011248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => CELLULOSIC FIBERS COMPRISING INTERNALLY DISPERSED CUPROUS OXIDE NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/371906
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371906
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371906 | CELLULOSIC FIBERS COMPRISING INTERNALLY DISPERSED CUPROUS OXIDE NANOPARTICLES | Jul 8, 2021 | Pending |
Array
(
[id] => 19338583
[patent_doc_number] => 12048754
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Dental desensitizer
[patent_app_type] => utility
[patent_app_number] => 17/363061
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2215
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17363061
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/363061 | Dental desensitizer | Jun 29, 2021 | Issued |
Array
(
[id] => 18116311
[patent_doc_number] => 11547683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Therapeutic compounds, formulations, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/305009
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21368
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305009 | Therapeutic compounds, formulations, and uses thereof | Jun 28, 2021 | Issued |
Array
(
[id] => 17170632
[patent_doc_number] => 20210324302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => OMEGA-3 FATTY ACID ESTER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/362129
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17362129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/362129 | OMEGA-3 FATTY ACID ESTER COMPOSITIONS | Jun 28, 2021 | Abandoned |
Array
(
[id] => 17843730
[patent_doc_number] => 11433072
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-09-06
[patent_title] => Oral dosage forms of ibrutinib
[patent_app_type] => utility
[patent_app_number] => 17/343900
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7564
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17343900
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/343900 | Oral dosage forms of ibrutinib | Jun 9, 2021 | Issued |
Array
(
[id] => 18201128
[patent_doc_number] => 11583499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 17/333629
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 64
[patent_no_of_words] => 58495
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17333629
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/333629 | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer | May 27, 2021 | Issued |
Array
(
[id] => 17050525
[patent_doc_number] => 20210259959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
[patent_app_type] => utility
[patent_app_number] => 17/315804
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/315804 | Treatment of epithelial cysts by intracystic injection of antineoplastic particles | May 9, 2021 | Issued |
Array
(
[id] => 17958517
[patent_doc_number] => 20220339097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => DISCONTINUOUS GUMMY DELIVERY SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/242030
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242030
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242030 | DISCONTINUOUS GUMMY DELIVERY SYSTEMS | Apr 26, 2021 | Pending |
Array
(
[id] => 17480423
[patent_doc_number] => 20220087927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => ANTIMICROBIAL AGENT
[patent_app_type] => utility
[patent_app_number] => 17/236055
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/236055 | Antimicrobial agent | Apr 20, 2021 | Issued |
Array
(
[id] => 17154761
[patent_doc_number] => 20210315812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => Structured Rheological Solid Personal Care Composition
[patent_app_type] => utility
[patent_app_number] => 17/225218
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225218
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/225218 | Structured Rheological Solid Personal Care Composition | Apr 7, 2021 | Pending |
Array
(
[id] => 16990092
[patent_doc_number] => 20210228512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/203639
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203639
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203639 | Therapeutic compounds, formulations, and uses thereof | Mar 15, 2021 | Issued |
Array
(
[id] => 17850546
[patent_doc_number] => 20220280587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => MEDICAL GELS CONTAINING A QUATERNARY AMMONIUM COMPOUND, PHENOXYETHANOL, ALOE VERA JUICE, AND NATURAL SPORICIDAL MOISTURIZERS
[patent_app_type] => utility
[patent_app_number] => 17/190628
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190628
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/190628 | MEDICAL GELS CONTAINING A QUATERNARY AMMONIUM COMPOUND, PHENOXYETHANOL, ALOE VERA JUICE, AND NATURAL SPORICIDAL MOISTURIZERS | Mar 2, 2021 | Abandoned |
Array
(
[id] => 17080570
[patent_doc_number] => 20210275576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR PREVENTION AND/OR IMPROVEMENT OF GENETIC DISORDER
[patent_app_type] => utility
[patent_app_number] => 17/189973
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189973
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/189973 | MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR PREVENTION AND/OR IMPROVEMENT OF GENETIC DISORDER | Mar 1, 2021 | Abandoned |
Array
(
[id] => 16898929
[patent_doc_number] => 20210177845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => PDE9 INHIBITORS FOR TREATING SICKLE CELL DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/186442
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17186442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/186442 | PDE9 INHIBITORS FOR TREATING SICKLE CELL DISEASE | Feb 25, 2021 | Pending |